A detailed history of Prentiss Smith & CO Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Prentiss Smith & CO Inc holds 20,852 shares of TECH stock, worth $1.61 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
20,852
Previous 20,852 -0.0%
Holding current value
$1.61 Million
Previous $1.49 Million 11.51%
% of portfolio
1.13%
Previous 1.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$62.12 - $84.15 $6,771 - $9,172
-109 Reduced 0.52%
20,852 $1.49 Million
Q1 2024

Apr 30, 2024

BUY
$65.98 - $77.09 $1.38 Million - $1.62 Million
20,961 New
20,961 $1.48 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.02B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Prentiss Smith & CO Inc Portfolio

Follow Prentiss Smith & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prentiss Smith & CO Inc with notifications on news.